Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. It operates through the following segments: Manufacturing and Selling of Medicines; and Sales and Distribution of Medicines and Healthcare Products. The company was founded on November 15, 1994 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company